These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16557993)

  • 21. Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes.
    Qoronfleh MW; Wilkinson BJ
    Antimicrob Agents Chemother; 1986 Feb; 29(2):250-7. PubMed ID: 2872855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.
    Zygmunt WA; Browder HP; Tavormina PA
    Appl Microbiol; 1968 Aug; 16(8):1168-73. PubMed ID: 5675508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW; Patron RL; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcal spheroplasts and L colonies. IV. Antimicrobial susceptibility of stable methicillin-induced and lysostaphin-induced spheroplasts.
    Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():382-7. PubMed ID: 5195739
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methicillin resistance and vancomycin susceptibility pattern among blood isolates of Staphylococcus aureus].
    Rodríguez-Pineda J; Terrazas-Estrada JJ; Urdez-Hernández E; Hernández-Sánchez EA; Sánchez-Tejeda SL
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):48-51. PubMed ID: 26820198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
    Polak J; Della Latta P; Blackburn P
    Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some differences in the action of penicillin, bacitracin, and vancomycin on Bacillus megaterium.
    Hancock R; Fitz-James PC
    J Bacteriol; 1964 May; 87(5):1044-50. PubMed ID: 4959792
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Raulinaitis V; Tossavainen H; Aitio O; Seppala R; Permi P
    Biomol NMR Assign; 2017 Apr; 11(1):69-73. PubMed ID: 27943001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BIOCHEMICAL EFFECTS OF NOVOBIOCIN ON STAPHYLOCOCCUS AUREUS.
    WISHNOW RM; STROMINGER JL; BIRGE CH; THRENN RH
    J Bacteriol; 1965 Apr; 89(4):1117-23. PubMed ID: 14276105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall.
    Krogstad DJ; Pargwette AR
    Antimicrob Agents Chemother; 1980 Jun; 17(6):965-8. PubMed ID: 6902640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANTIMICROBIAL CHEMOTHERAPEUTIC AGENTS: THE NATURE OF THEIR ACTION AND SELECTIVE TOXICITY.
    FEINGOLD DS
    N Engl J Med; 1963 Oct; 269():900-7 CONTD. PubMed ID: 14050990
    [No Abstract]   [Full Text] [Related]  

  • 32. COMPARATIVE IN VITRO ACTIVITIES OF LYSOSTAPHIN AND OTHER ANTISTAPHYLOCOCCAL ANTIBIOTICS ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.
    HARRISON EF; CROPP CB
    Appl Microbiol; 1965 Mar; 13(2):212-5. PubMed ID: 14325881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics.
    Sieradzki K; Tomasz A
    J Antimicrob Chemother; 1997 May; 39 Suppl A():47-51. PubMed ID: 9511062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibilities of four species of coagulase-negative staphylococci.
    Fass RJ; Helsel VL; Barnishan J; Ayers LW
    Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular mechanism of inhibition of biosynthesis of peptidoglycan of bacterial cell walls by antibiotics].
    Torbochkina LI
    Antibiotiki; 1970 May; 15(5):465-76. PubMed ID: 4915727
    [No Abstract]   [Full Text] [Related]  

  • 36. EFFECT OF ANTIBIOTICS AND INHIBITORS ON M PROTEIN SYNTHESIS.
    BROCK TD
    J Bacteriol; 1963 Mar; 85(3):527-31. PubMed ID: 14042928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of action of some antibacterial agents.
    Russell AD
    Prog Med Chem; 1969; 6():135-99. PubMed ID: 4307054
    [No Abstract]   [Full Text] [Related]  

  • 38. Different formulations of vancomycin: In vitro antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Fabri FV; Lolis MA; Gimenes M; Tognim MCB; Caparroz-Assef SM
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):332-337. PubMed ID: 30033164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity.
    Severance PJ; Kauffman CA; Sheagren JN
    J Clin Microbiol; 1980 Jun; 11(6):724-7. PubMed ID: 7430338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
    Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.